"Ketanserin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
Descriptor ID |
D007650
|
MeSH Number(s) |
D03.383.621.365 D03.633.100.786.830.333
|
Concept/Terms |
Ketanserin- Ketanserin
- 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione
R-41,468- R-41,468
- R 41,468
- R41,468
- R-41468
- R 41468
- R41468
|
Below are MeSH descriptors whose meaning is more general than "Ketanserin".
Below are MeSH descriptors whose meaning is more specific than "Ketanserin".
This graph shows the total number of publications written about "Ketanserin" by people in this website by year, and whether "Ketanserin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Ketanserin" by people in Profiles.
-
Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial. Circulation. 1993 Oct; 88(4 Pt 1):1588-601.